Search for: "Astrazeneca LP"
Results 41 - 60
of 155
Sorted by Relevance
|
Sort by Date
13 Feb 2012, 1:47 pm
LP. v. [read post]
29 Mar 2012, 5:47 am
District Court for the District of Columbia denied AstraZeneca Pharmaceuticals LP’s (“AstraZeneca’s”) Motion for Temporary Restraining Order (Complaint here) seeking to vacate FDA’s March 27, 2012 approval of more than 10 ANDAs for generic versions of AstraZeneca’s blockbuster antipsychotic drug SEROQUEL (quetiapine fumarate) Tablets (NDA No. 020639), and to enjoin FDA from granting any further final ANDA approvals for the drug… [read post]
4 Nov 2010, 10:59 am
By Jason Rantanen AstraZeneca LP v. [read post]
17 Jul 2012, 4:40 am
See AstraZeneca LP v. [read post]
28 Apr 2010, 7:00 am
Cuomo today announced that New York state will receive nearly $45 million as part of a $520 million federal and multi-state settlement with AstraZeneca LP (NYSE: AZN) concerning allegations that the large pharmaceutical company provided kickbacks to doctors and engaged in an off-label marketing campaign to promote its antipsychotic drug Seroquel. [read post]
13 Nov 2013, 9:14 pm
By Donald Zuhn -- In an appeal decided last month, the Federal Circuit reversed and remanded a decision of noninfringement by the District Court for the District of New Jersey with respect to U.S. [read post]
28 Apr 2010, 7:14 am
From the DOJ Press Statement:AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Departments of Justice and Health and Human Services’ Health Care Fraud Enforcement Action Team (HEAT) announced today. [read post]
21 Dec 2015, 5:43 pm
” AstraZeneca LP v. [read post]
12 Feb 2018, 12:05 pm
According to that JPML Transfer Order the Defendants -- AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Co., and McKesson Corp. -- opposed centralization of approximately 80 Onglyza and Kombiglyze lawsuits into this new MDL: Defendants oppose transfer by arguing that plaintiffs’ allegations are supported by a single study (the SAVOR study), which itself supports only claims regarding heart failure – not the various other injuries (congestive heart failure, acute… [read post]
17 Aug 2020, 10:03 am
AstraZeneca Pharmaceuticals LP, Civil Action No. 19-2320-RGA (D.Del. [read post]
16 Apr 2010, 3:30 am
AstraZeneca Pharmaceuticals, LP, 2010 WL 1267219 (Del. [read post]
27 Feb 2012, 3:30 am
AstraZeneca Pharmaceuticals, LP, No. 1:10CV104-SA-JAD, 2010 WL 3951906 (N.D. [read post]
2 Dec 2011, 1:11 pm
LP, 748 F. [read post]
28 Sep 2009, 9:56 pm
Sometimes, Sins of Omission Are Not Inequitable Conduct By Kevin E. [read post]
11 Mar 2011, 11:46 am
AstraZeneca Pharmaceuticals LP, 2011 WL 833222, slip op. (11th Cir. [read post]
2 Nov 2010, 1:40 am
AstraZeneca v. [read post]
12 Jun 2008, 4:45 am
Omeprazole is the active ingredient in Prilosec ®, which is marketed by Plaintiffs-Appellants Astrazeneca, AB, Aktiebolaget Hassle, KBI-E, Inc., KBI, Inc., and Astrazeneca LP (Astrazeneca) for the treatment of gastric and duodenal ulcers, and which acts by inhibiting the production of gastric acid. [read post]
8 Feb 2009, 9:35 pm
AstraZeneca Pharmaceuticals LP, No. 6:07-cv-15733-Orl-22DAB, slip op. [read post]
11 Dec 2011, 9:00 pm
AstraZeneca Pharmaceuticals LP, the Federal Circuit explained when a secret invention can be considered "made" (or conceived and reduced to practice) so that it can be used as prior art against a patent. [read post]
11 Dec 2011, 9:00 pm
AstraZeneca Pharmaceuticals LP, the Federal Circuit explained when a secret invention can be considered "made" (or conceived and reduced to practice) so that it can be used as prior art against a patent. [read post]
